| 1 |
35169858 | Inhibition of the VEGF signaling pathway attenuates tumor‑associated macrophage activity in liver cancer. | 2022 Apr |
8 |
| 2 |
35231032 | Hypoxia-induced interstitial transformation of microvascular endothelial cells by mediating HIF-1α/VEGF signaling in systemic sclerosis. | 2022 |
1 |
| 3 |
34439098 | CCL20/TNF/VEGFA Cytokine Secretory Phenotype of Tumor-Associated Macrophages Is a Negative Prognostic Factor in Cutaneous Melanoma. | 2021 Aug 5 |
1 |
| 4 |
30444717 | Lymph/angiogenesis contributes to sex differences in lung cancer through oestrogen receptor alpha signalling. | 2019 Feb |
1 |
| 5 |
31824163 | The Effect of Coenzyme Q10 Supplementation on Vascular Endothelial Growth Factor and Serum Levels of Interleukin 6 and 8 in Women with Breast Cancer: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. | 2019 |
1 |
| 6 |
30207246 | A Review on The Role of VEGF in Tamoxifen Resistance. | 2018 |
6 |
| 7 |
28153880 | Tamoxifen Directly Inhibits Platelet Angiogenic Potential and Platelet-Mediated Metastasis. | 2017 Apr |
2 |
| 8 |
26349973 | BI2536--A PLK inhibitor augments paclitaxel efficacy in suppressing tamoxifen induced senescence and resistance in breast cancer cells. | 2015 Aug |
2 |
| 9 |
26450919 | Pigment Epithelium-Derived Factor Alleviates Tamoxifen-Induced Endometrial Hyperplasia. | 2015 Dec |
1 |
| 10 |
24497234 | Synthesis, biological evaluation, and docking studies of new 2-furylbenzimidazoles as anti-angiogenic agents: part II. | 2014 Apr |
1 |
| 11 |
24519842 | m-TOR inhibitors may be useful in the treatment of encapsulating peritoneal sclerosis (EPS). | 2014 Oct |
1 |
| 12 |
24535190 | COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro. | 2014 Apr |
3 |
| 13 |
23212665 | Effect of tamoxifen, methoxyprogesterone acetate and combined treatment on cellular proliferation and apoptosis in SKOV3/DDP cells via the regulation of vascular endothelial growth factor. | 2013 May |
2 |
| 14 |
23731702 | Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling. | 2013 Jun 3 |
6 |
| 15 |
24377619 | Synergistic effects of tamoxifen and tranilast on VEGF and MMP-9 regulation in cultured human breast cancer cells. | 2013 |
2 |
| 16 |
22531128 | Tamoxifen modulates cell migration and expression of angiogenesis-related genes in human endometrial endothelial cells. | 2012 Jun |
5 |
| 17 |
22842120 | Amurensin G inhibits angiogenesis and tumor growth of tamoxifen-resistant breast cancer via Pin1 inhibition. | 2012 Oct |
2 |
| 18 |
21291529 | The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen. | 2011 Feb 3 |
1 |
| 19 |
21984941 | Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo. | 2011 |
3 |
| 20 |
20374029 | Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab. | 2010 Apr |
1 |
| 21 |
20413297 | Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF. | 2010 Jun |
6 |
| 22 |
20680681 | Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients. | 2010 Oct |
3 |
| 23 |
20804812 | Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells. | 2010 Nov |
2 |
| 24 |
19148513 | Regulation of the vascular endothelial growth factor and growth by estrogen and antiestrogens through Efp in Ishikawa endometrial carcinoma cells. | 2009 Feb |
3 |
| 25 |
19671742 | Enhancement of vascular endothelial growth factor-mediated angiogenesis in tamoxifen-resistant breast cancer cells: role of Pin1 overexpression. | 2009 Aug |
3 |
| 26 |
18451229 | The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer. | 2008 May 1 |
6 |
| 27 |
18483373 | Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer. | 2008 May 15 |
4 |
| 28 |
18676847 | Vascular endothelial growth factor reduces tamoxifen efficacy and promotes metastatic colonization and desmoplasia in breast tumors. | 2008 Aug 1 |
8 |
| 29 |
18922978 | An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells. | 2008 Oct |
7 |
| 30 |
17564928 | Intravitreous vascular endothelial growth factor (VEGF) inhibitor therapy for tamoxifen induced macular edema. | 2007 Apr-Jun |
2 |
| 31 |
16965743 | [Effects of Runing Recipe medicated serum on expressions of genes in breast cancer cells]. | 2006 Sep |
1 |
| 32 |
16982990 | Effects of tamoxifen on normal human dermal fibroblasts. | 2006 Sep-Oct |
1 |
| 33 |
16990991 | Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells? | 2006 Nov |
1 |
| 34 |
15692755 | Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response. | 2005 Jan |
5 |
| 35 |
16034044 | Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer. | 2005 Jul 20 |
2 |
| 36 |
16234819 | Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells. | 2005 Oct 31 |
2 |
| 37 |
14996734 | PC cell-derived growth factor mediates tamoxifen resistance and promotes tumor growth of human breast cancer cells. | 2004 Mar 1 |
1 |
| 38 |
15026368 | Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B. | 2004 Mar 15 |
2 |
| 39 |
15067354 | Reduction of CWR22 prostate tumor xenograft growth by combined tamoxifen-quercetin treatment is associated with inhibition of angiogenesis and cellular proliferation. | 2004 May |
2 |
| 40 |
15213909 | Synergistic effect of estrogen and VEGF on the proliferation of hemangioma vascular endothelial cells. | 2004 Jul |
1 |
| 41 |
15320904 | Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients. | 2004 Sep |
4 |
| 42 |
15640959 | Early nuclear alterations and immunohistochemical expression of Ki-67, Erb-B2, vascular endothelial growth factor (VEGF), transforming growth factor (TGF-beta1) and integrine-linked kinase (ILK) two days after tamoxifen in breast carcinoma. | 2004 |
1 |
| 43 |
15736439 | Effect of estrogen, tamoxifen and epidermal growth factor on the transcriptional regulation of vascular endothelial growth factor in breast cancer cells. | 2004 Nov-Dec |
3 |
| 44 |
12684392 | Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer. | 2003 Apr |
6 |
| 45 |
12771461 | Regulation of vascular endothelial growth factor by tamoxifen in vitro and in vivo. | 2003 |
6 |
| 46 |
12865915 | Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen. | 2003 Jul 21 |
2 |
| 47 |
14695189 | Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo. | 2003 Dec 15 |
5 |
| 48 |
11836562 | Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment. | 2002 Mar |
1 |
| 49 |
11929808 | Hormonal regulation of VEGF in orthotopic MCF7 human breast cancer. | 2002 Apr 1 |
3 |
| 50 |
12208749 | Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. | 2002 Sep 1 |
3 |